Real-time enrollment status for this hypereosinophilic syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: September 2, 2026 at 6:29 AM UTC
| NCT Number | NCT03801434 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Hypereosinophilic Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 10 participants |
| Active Locations | 4 sites in the US |
| Sponsor | William Shomali |
| Last Updated on CT.gov | September 1, 2026 (Yesterday) |
As of September 2, 2026: Clinical trial NCT03801434 is currently active_not_recruiting participants. This phase2 study for hypereosinophilic syndrome is not currently accepting new participants at 4 locations across the United States. The study is sponsored by William Shomali. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03801434 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03801434 was last updated Yesterday (September 1, 2026). HelloStudys verifies this status automatically.